Nanologica: Delivery for full-scale production - Redeye

Today, Nanologica announced that it has successfully fulfilled an order placed last year for the evaluation of full-scale production by an insulin manufacturer in Asia. The customer is described as "one of the world's largest insulin manufacturers." We see this as a concrete step forward for Nanologica, and consider today's share price surge justified. Later today, we will be recording an interview with the CEO, Andreas Bhagwani, to delve deeper into this exciting news.

Länk till analysen i sin helhet: https://www.redeye.se/research/947383/nanologica-delivery-for-full-scale-production?utm_source=finwire&utm_medium=RSS